Pharmafile Logo
Pharmafocus logo
Advanced Search

Strategic alliance for treatment of glaucoma

July 21, 2022
Business Services

AbbVie and iSTAR Medical SA have announced a strategic transaction to further develop and commercialise iSTAR Medical’s MINIject® device. The …

News

First disease-modifying treatment for AADC deficiency

July 21, 2022
Business Services

The European Commission (EC) has granted a marketing authorisation for Upstaza™ (eladocagene exuparvovec), the world’s first disease-modifying treatment for aromatic …

News

Transformational therapy cures bleeding disorder haemophilia B

July 21, 2022
Business Services

Researchers have found that a single injection of a new gene therapy, called FLT180a, removed the need for people to …

News

Depression may not be caused by chemical imbalance

July 20, 2022
Research and Development

A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …

News

COVID-19 boosters to be offered to all over 50s this autumn

July 20, 2022
Research and Development

All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity …

News

Potential shortage of 140,000 nurses in NHS England by 2030

July 20, 2022
Research and Development

According to new analysis, the NHS in England could face a shortfall of almost 40,000 nurses by 2024, and under …

News

TSB and CR Pharma partner for COVID-19 antibody therapy in China

July 20, 2022
Research and Development

TSB Therapeutics has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody …

News

Brain cancer treatment receives Orphan Drug Designation

July 19, 2022
Manufacturing and Production

The FDA has granted an Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of …

News

MIT research demonstrates potential of self-boosting vaccines

July 19, 2022
Manufacturing and Production

In a new study, MIT researchers describe the analysis of a release mechanism from biodegradable core-shell microparticles.Through understanding how and …

News

New reforms aim for better NHS dental service access

July 19, 2022
Manufacturing and Production

Patients across the country will benefit from improved access to dental care under changes announced by NHS England, the organisation …

News

WHO to assist Ghana following confirmed Marburg cases

July 19, 2022
Manufacturing and Production

WHO has announced that in the coming days it will deploy a team of experts to assist Ghana in tackling …

News
alina-grubnyak-tevgmmapfxk-unsplash

FDA approval for neurostimulation device to treat diabetic neuropathic pain

July 15, 2022
Medical Communications

DyAnsys has received FDA approval for its First Relief device, a wearable device monitoring pulses of a low-level electrical current …

News

Step strategy effective in treating diabetic eye disease

July 15, 2022
Medical Communications

An NIH-funded clinical from the DRCR Retina Network suggests that a specific step strategy for patients with diabetic macular edema …

News

FDA approves new treatment for rare tumour

July 15, 2022
Medical Communications

The FDA has approved crizotinib for adult and paediatric patients aged 1 year and older with unresectable, recurrent, or refractory …

News

First immunotherapy for untreated, unresectable malignant pleural mesothelioma recommended by NICE

July 14, 2022
Business Services

Bristol Myers Squibb (BMS) has announced that the NICE Final Appraisal Document (FAD) recommending the combination of nivolumab plus ipilimumab …

News

Trodelvy recommended in England for metastatic triple negative breast cancer

July 14, 2022
Business Services

Gilead Sciences has announced the NICE recommendation of Trodelvy (sacituzumab govitecan) for use on the NHS in England, as an …

News

Nucleai partners with Sirona Dx for AI-driven discovery of biomarkers in solid tumours

July 14, 2022
Business Services

Nuclei and Sirona Dx have announced a collaboration to advance the discovery of novel spatial biomarkers in solid tumours.The partnership …

News

Gene editing potential treatment for hereditary killer

July 13, 2022
Research and Development

Verve therapeutics has dosed the first patient win its heart-1 clinical trial, studying the safety and efficacy of its in …

News

FDA accepts Byondis’ Biologics License Application for breast cancer treatment

July 13, 2022
Research and Development

The FDA has accepted Byondis’ submission of a Biologics License Application (BLA) for [vic-] trastuzumab duocarmazine (SYD985) in patients with …

News

Trial of mRNA first Nipah virus vaccine

July 13, 2022
Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026